Cardiometabolic Disease Update: 12 Studies


Less than 7% of the US population has optimal cardiometabolic health according to a novel study that assessed 5 key components of the measure. That disappointing metric and others like it have fueled a surge in research into cardiometabolic disease pathophysiology, prevention, and treatment.

Click through the 12 slides in this update for an at-a-glance overview of 2022's most promising cardiometabolic research to date.

CKD, Heart Failure, Hypertension, MACE, NAFLD/NASH, Type 2 Diabetes

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2023 MJH Life Sciences

All rights reserved.